COMMUNIQUÉS West-GlobeNewswire

-
Allscripts Joins with Microsoft to Explore Technology for Clinical Research
07/01/2019 -
Sientra Announces Preliminary Unaudited Fourth Quarter 2018 Net Sales and Appointment of Aesthetic Industry Veteran to Board of Directors
07/01/2019 -
BioTime Enters Into Exclusive Agreement With Orbit Biomedical Ltd. to Access Innovative Device for the Sub-Retinal Delivery of OpRegen® Cells for the Treatment of Dry-AMD
07/01/2019 -
Allakos Announces Positive Phase 2 Results in a Cohort of Xolair-Naïve Chronic Spontaneous Urticaria Patients
07/01/2019 -
Neuronetics Announces Preliminary Fourth Quarter and Full Year Revenue
07/01/2019 -
Long-Term Study of 1,000 Tumors Demonstrates Effectiveness of iCAD's Xoft Electronic Brachytherapy System for Early-Stage Breast Cancer Treatment
07/01/2019 -
Aulisa Medical USA, Inc. Enters Market With Wearable, Wireless Continuous Vital Signs Monitoring & Alarm Systems
07/01/2019 -
Rubius Therapeutics Highlights Upcoming 2019 Milestones at the 37th Annual J.P. Morgan Healthcare Conference
07/01/2019 -
Tabula Rasa HealthCare Completes Acquisition of DoseMe
07/01/2019 -
Tauriga Sciences, Inc. to Launch an E-Commerce Site to Coincide with the Commercial Launch of its Cannabis/CBD Infused Chewing Gum Product Line
07/01/2019 -
Orchard Therapeutics Highlights Recent Accomplishments and 2019 Strategic Priorities as a Global Leader in Gene Therapy
07/01/2019 -
CareDx Reports Preliminary Fourth Quarter and Full Year 2018 Financial Results
07/01/2019 -
Fertin Pharma’s Parent Company Acquires MedCan Pharma - Allowing Entry into Fast-growing Market for Cannabinoid Products
07/01/2019 -
Nuvectra® Announces Preliminary Unaudited Fourth Quarter and Full Year 2018 Revenue
07/01/2019 -
Tecan to present at J.P. Morgan Healthcare Conference
07/01/2019 -
Vital Therapies and Immunic Therapeutics Announce Transaction to Create Leading Inflammatory and Autoimmune Disease Company
07/01/2019 -
FIT Biotech Oy: Changes in FIT Biotech's Board of Directors
07/01/2019 -
Sanofi and Regeneron Restructure Immuno-Oncology Collaboration for Discovery and Development Programs
07/01/2019 -
Sanofi et Regeneron restructurent leur collaboration de recherche et développement en immuno-oncologie
07/01/2019
Pages